Takashi Nagai

Luteolin suppresses bladder cancer growth via regulation of mechanistic target of rapamycin pathway

Keitaro Iida, Taku Naiki, Aya Naiki‐Ito et al. · Cancer Science · 2020 · 88 citations · Full text

Medicine, Oncology, Pharmacology +16

Low Geriatric Nutritional Risk Index as a Poor Prognostic Marker for Second-Line Pembrolizumab Treatment in Patients with Metastatic Urothelial Carcinoma: A Retrospective Multicenter Analysis

Toshiki Etani, Taku Naiki, Yosuke Sugiyama et al. · Oncology · 2020 · 29 citations

Medicine, Oncology, Pharmacology +17

Transcatheter Arterial Embolization for Renal Angiomyolipoma Using a Micro-balloon Catheter and a Mixture of Ethanol and Lipiodol

Yusuke Sawada, Masashi Shimohira, Takuya Hashizume et al. · CardioVascular and Interventional Radiology · 2017 · 23 citations

Medicine, Nephrology, Surgery +12

Chronological transition in outcome of second-line treatment in patients with metastatic urothelial cancer after pembrolizumab approval: a multicenter retrospective analysis

Teruki Isobe, Taku Naiki, Yosuke Sugiyama et al. · International Journal of Clinical Oncology · 2021 · 17 citations

Medicine, Oncology, Pharmacotherapy +13

Drug Release Stimulated by Magnetic Field and Light on Magnetite- and Carbon Dot-Loaded Carbon Nanohorn

Chin-Hao Su, Andree Soendoro, Shinya Okayama et al. · Bulletin of the Chemical Society of Japan · 2022 · 16 citations

Pharmacy, Materials Science, Pharmaceutics +17